Skip to main content

DINAMICA DE LA PARED BACTERIANA: DESCIFRANDO LOS MECANISMOS DE REGULACION Y DE RESISTENCIA A ANTIBIOTICOS

PID2023-153118OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2023
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Structural and Kinetic Variability of Pathogen Cyclophilins: Functional Diversification and Therapeutic Potential

  • Favretto, Filippo
  • Jiménez-Faraco, Eva
  • Fruncillo, Silvia
  • Masè, Nicola
  • Dominici, Paola
  • Hermoso, Juan A.
  • Astegno, Alessandra
Cyclophilins are a highly conserved family of peptidyl-prolyl cis-trans isomerases (PPIases) that play essential roles in protein folding, trafficking, and cellular stress adaptation across all domains of life. While extensively studied in humans, cyclophilins from pathogenic microorganisms have garnered growing interest due to their involvement in virulence, immune evasion, and antimicrobial resistance. Unlike bacteria, which typically encode only one or two isoforms, many protozoan parasites possess expanded cyclophilin repertoires, raising important questions about whether these proteins perform redundant functions or have evolved distinct roles in pathogenesis. Despite their biological relevance, detailed structural and mechanistic studies of microbial cyclophilins remain limited. This review focuses on the structural variability and kinetic diversity of pathogen-derived cyclophilins, emphasizing how differences in three-dimensional architecture, enzymatic kinetics, and ligand-binding properties distinguish these enzymes from their host homologues. It also provides an overview of the therapeutic landscape, highlighting natural product-based pan-selective inhibitors such as cyclosporin A and sanglifehrin A, their nonimmunosuppressive analogues, and the recent development of more selective synthetic scaffolds with improved drug-like properties. Deciphering the structural features, enzymatic behavior, and druggability of microbial cyclophilins is key to unlocking their full therapeutic potential., The research was supported by the European Union-NextGenerationEU Italian PRIN 2022 PNRR grant No. P2022TY8K5 (to FF) and by the European Union-NextGenerationEU Italian PRIN 2022 grant No. 20224BYR59 (to AA). The work was also supported by the grant PID2023-153118OB-I00, awarded by MCIN/AEI/10.13039/501100011033 (to JAH). The graphical abstract was created with BioRender.com., Peer reviewed